Alerts will be sent to your verified email
Verify Email
OXYGENTAPH
|
Oxygenta Pharma
|
Natural Capsules
|
Sat Kartar Shopping
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.1 % | 9.1 % | 85.71 % |
|
5yr average Equity Multiplier
|
-1.22 | 1.91 | 5.87 |
|
5yr Average Asset Turnover Ratio
|
1.1 | 0.61 | 4.67 |
|
5yr Avg Net Profit Margin
|
-16.74 % | 6.68 % | 4.16 % |
|
Price to Book
|
0.0 | 1.09 | 4.89 |
|
P/E
|
0.0 | 0.0 | 25.64 |
|
5yr Avg Cash Conversion Cycle
|
-56.32 Days | 25.72 Days | -188.77 Days |
|
Inventory Days
|
94.46 Days | 27.47 Days | 2.8 Days |
|
Days Receivable
|
80.66 Days | 125.88 Days | 9.28 Days |
|
Days Payable
|
174.19 Days | 118.63 Days | 183.86 Days |
|
5yr Average Interest Coverage Ratio
|
-3.11 | 7.96 | 13.86 |
|
5yr Avg ROCE
|
-80.86 % | 10.02 % | 56.52 % |
|
5yr Avg Operating Profit Margin
|
-18.99 % | 14.83 % | 6.86 % |
|
5 yr average Debt to Equity
|
-1.55 | 0.51 | 3.01 |
|
5yr CAGR Net Profit
|
-9.68 % | -38.15 % | 47.82 % |
|
5yr Average Return on Assets
|
-10.42 % | 4.68 % | 18.52 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
57.92 % | 51.26 % | 63.34 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
45.59 % | -5.31 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.04 % | 0.0 | 0.0 |
|
Oxygenta Pharma
|
Natural Capsules
|
Sat Kartar Shopping
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|